 Jordan Karlitz
Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 22 | 2022 | 615 | 6.240 |
Why?
| | Early Detection of Cancer | 13 | 2022 | 328 | 3.320 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 5 | 2021 | 30 | 3.030 |
Why?
| | Carcinoid Tumor | 3 | 2022 | 25 | 2.270 |
Why?
| | Adenocarcinoma | 6 | 2022 | 795 | 1.970 |
Why?
| | Colonoscopy | 8 | 2021 | 204 | 1.350 |
Why?
| | Colonic Neoplasms | 5 | 2022 | 215 | 1.260 |
Why?
| | Telemedicine | 3 | 2021 | 662 | 1.240 |
Why?
| | Mass Screening | 6 | 2022 | 1004 | 0.960 |
Why?
| | Genetic Testing | 2 | 2018 | 379 | 0.920 |
Why?
| | Appendiceal Neoplasms | 1 | 2022 | 14 | 0.820 |
Why?
| | SEER Program | 7 | 2022 | 196 | 0.800 |
Why?
| | Adenoma | 2 | 2021 | 189 | 0.760 |
Why?
| | Immunohistochemistry | 5 | 2021 | 1629 | 0.750 |
Why?
| | Disease Transmission, Infectious | 1 | 2020 | 55 | 0.690 |
Why?
| | Incidence | 8 | 2022 | 2313 | 0.690 |
Why?
| | Health Status Disparities | 2 | 2020 | 200 | 0.650 |
Why?
| | Microsatellite Instability | 2 | 2018 | 32 | 0.640 |
Why?
| | Colonic Polyps | 1 | 2020 | 67 | 0.630 |
Why?
| | United States | 15 | 2022 | 12181 | 0.600 |
Why?
| | Practice Patterns, Physicians' | 2 | 2018 | 1177 | 0.590 |
Why?
| | Betacoronavirus | 1 | 2020 | 250 | 0.570 |
Why?
| | Age of Onset | 5 | 2022 | 446 | 0.540 |
Why?
| | Colectomy | 2 | 2015 | 86 | 0.520 |
Why?
| | Family | 1 | 2020 | 589 | 0.520 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 338 | 0.500 |
Why?
| | Coronavirus Infections | 1 | 2020 | 330 | 0.500 |
Why?
| | Humans | 37 | 2022 | 114662 | 0.470 |
Why?
| | Rectal Neoplasms | 3 | 2021 | 121 | 0.460 |
Why?
| | Age Factors | 6 | 2022 | 2894 | 0.460 |
Why?
| | Colorectal Surgery | 1 | 2013 | 21 | 0.440 |
Why?
| | Pandemics | 1 | 2020 | 1317 | 0.400 |
Why?
| | Adult | 17 | 2022 | 30544 | 0.380 |
Why?
| | Middle Aged | 15 | 2022 | 26733 | 0.380 |
Why?
| | Immunocompetence | 1 | 2010 | 40 | 0.360 |
Why?
| | Germ-Line Mutation | 2 | 2021 | 130 | 0.350 |
Why?
| | Herpesvirus 4, Human | 1 | 2010 | 125 | 0.340 |
Why?
| | Risk Assessment | 4 | 2022 | 2968 | 0.330 |
Why?
| | Louisiana | 2 | 2021 | 23 | 0.320 |
Why?
| | Colitis | 1 | 2010 | 223 | 0.300 |
Why?
| | Male | 15 | 2022 | 55583 | 0.290 |
Why?
| | Carcinoma | 2 | 2021 | 198 | 0.280 |
Why?
| | Risk Factors | 6 | 2022 | 8632 | 0.270 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2010 | 284 | 0.270 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 2 | 2017 | 228 | 0.270 |
Why?
| | Uterine Diseases | 1 | 2006 | 14 | 0.270 |
Why?
| | Colonic Diseases | 1 | 2006 | 25 | 0.270 |
Why?
| | Endometriosis | 1 | 2006 | 40 | 0.260 |
Why?
| | Female | 15 | 2022 | 59493 | 0.250 |
Why?
| | Occult Blood | 2 | 2021 | 26 | 0.240 |
Why?
| | Neoplasm Staging | 4 | 2022 | 1167 | 0.240 |
Why?
| | Rural Population | 2 | 2018 | 446 | 0.220 |
Why?
| | Clinical Competence | 1 | 2009 | 893 | 0.200 |
Why?
| | Appendectomy | 1 | 2022 | 67 | 0.200 |
Why?
| | Cross-Sectional Studies | 3 | 2021 | 4408 | 0.200 |
Why?
| | Cost-Benefit Analysis | 2 | 2021 | 544 | 0.200 |
Why?
| | MutL Protein Homolog 1 | 1 | 2021 | 9 | 0.190 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2021 | 18 | 0.190 |
Why?
| | DNA Mismatch Repair | 1 | 2021 | 37 | 0.190 |
Why?
| | Forecasting | 2 | 2020 | 330 | 0.190 |
Why?
| | Patient Compliance | 2 | 2021 | 525 | 0.170 |
Why?
| | Mutation, Missense | 1 | 2021 | 293 | 0.170 |
Why?
| | Diagnosis, Differential | 2 | 2016 | 1342 | 0.160 |
Why?
| | Pathologists | 1 | 2018 | 15 | 0.160 |
Why?
| | Insurance, Health | 1 | 2020 | 244 | 0.160 |
Why?
| | Gastroenterologists | 1 | 2018 | 18 | 0.150 |
Why?
| | Lymph Nodes | 2 | 2014 | 419 | 0.150 |
Why?
| | Feasibility Studies | 1 | 2021 | 740 | 0.150 |
Why?
| | Medicaid | 1 | 2021 | 406 | 0.150 |
Why?
| | Congresses as Topic | 1 | 2019 | 195 | 0.150 |
Why?
| | Retrospective Studies | 4 | 2021 | 12546 | 0.140 |
Why?
| | Organizational Objectives | 1 | 2017 | 66 | 0.140 |
Why?
| | Medicare | 2 | 2021 | 665 | 0.140 |
Why?
| | Physician's Role | 1 | 2018 | 197 | 0.140 |
Why?
| | DNA Mutational Analysis | 1 | 2017 | 372 | 0.130 |
Why?
| | Neoplastic Syndromes, Hereditary | 1 | 2016 | 30 | 0.130 |
Why?
| | Physician-Patient Relations | 1 | 2020 | 462 | 0.130 |
Why?
| | Health Care Costs | 1 | 2018 | 381 | 0.120 |
Why?
| | Preoperative Period | 1 | 2015 | 103 | 0.120 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2015 | 52 | 0.120 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1355 | 0.110 |
Why?
| | Preoperative Care | 1 | 2016 | 319 | 0.110 |
Why?
| | Neoplasms, Second Primary | 1 | 2015 | 92 | 0.110 |
Why?
| | Societies, Medical | 1 | 2017 | 663 | 0.110 |
Why?
| | Health Services Accessibility | 1 | 2018 | 762 | 0.100 |
Why?
| | Urban Population | 1 | 2015 | 397 | 0.100 |
Why?
| | Endoscopy, Gastrointestinal | 2 | 2010 | 203 | 0.100 |
Why?
| | Quality Improvement | 1 | 2018 | 950 | 0.090 |
Why?
| | Jejunal Diseases | 1 | 2010 | 7 | 0.090 |
Why?
| | Young Adult | 3 | 2020 | 10466 | 0.090 |
Why?
| | Veterans | 1 | 2021 | 1249 | 0.090 |
Why?
| | Choristoma | 1 | 2010 | 23 | 0.090 |
Why?
| | Abdominal Pain | 2 | 2010 | 135 | 0.080 |
Why?
| | Ribavirin | 1 | 2010 | 89 | 0.080 |
Why?
| | Interferon-alpha | 1 | 2010 | 186 | 0.080 |
Why?
| | Prevalence | 1 | 2015 | 2251 | 0.080 |
Why?
| | Pancreas | 1 | 2010 | 276 | 0.080 |
Why?
| | Brain Neoplasms | 1 | 2016 | 979 | 0.070 |
Why?
| | Hepatitis C | 1 | 2010 | 219 | 0.070 |
Why?
| | Registries | 1 | 2014 | 1768 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 4622 | 0.070 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1075 | 0.070 |
Why?
| | Ovariectomy | 1 | 2006 | 116 | 0.070 |
Why?
| | Biopsy, Needle | 1 | 2006 | 182 | 0.060 |
Why?
| | Hysterectomy | 1 | 2006 | 106 | 0.060 |
Why?
| | Polyethylene Glycols | 1 | 2010 | 561 | 0.060 |
Why?
| | Vasculitis | 1 | 2005 | 66 | 0.060 |
Why?
| | Antiviral Agents | 1 | 2010 | 645 | 0.060 |
Why?
| | Time Factors | 1 | 2015 | 6115 | 0.060 |
Why?
| | Aged | 5 | 2021 | 19069 | 0.060 |
Why?
| | Brain Diseases | 1 | 2005 | 125 | 0.060 |
Why?
| | Celiac Disease | 1 | 2005 | 264 | 0.050 |
Why?
| | Europe | 1 | 2022 | 334 | 0.050 |
Why?
| | North America | 1 | 2022 | 256 | 0.050 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2021 | 332 | 0.040 |
Why?
| | Disease Progression | 1 | 2006 | 2380 | 0.040 |
Why?
| | Colonography, Computed Tomographic | 1 | 2018 | 3 | 0.040 |
Why?
| | Feces | 1 | 2021 | 373 | 0.040 |
Why?
| | Follow-Up Studies | 1 | 2006 | 4411 | 0.040 |
Why?
| | Mutation | 2 | 2017 | 3345 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2017 | 6345 | 0.030 |
Why?
| | Carcinoembryonic Antigen | 1 | 2014 | 37 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1211 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2022 | 2085 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 1715 | 0.030 |
Why?
| | Prognosis | 1 | 2021 | 3329 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2006 | 9088 | 0.030 |
Why?
| | Urban Health | 1 | 2010 | 73 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2010 | 951 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2017 | 5045 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2010 | 1230 | 0.020 |
Why?
| | CD2 Antigens | 1 | 2005 | 5 | 0.020 |
Why?
| | Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 2005 | 8 | 0.020 |
Why?
| | Complement C4b | 1 | 2005 | 9 | 0.020 |
Why?
| | Complement C1q | 1 | 2005 | 36 | 0.020 |
Why?
| | CD3 Complex | 1 | 2005 | 92 | 0.020 |
Why?
| | Cohort Studies | 1 | 2014 | 4895 | 0.020 |
Why?
| | Infant | 1 | 2017 | 7961 | 0.010 |
Why?
| | Fatal Outcome | 1 | 2005 | 284 | 0.010 |
Why?
| | Complement C3 | 1 | 2005 | 188 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 9114 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 993 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2005 | 666 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 17841 | 0.010 |
Why?
| | Child | 1 | 2017 | 18412 | 0.010 |
Why?
|
|
Karlitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|